Znanstveni rad - Izvorni znanstveni rad
The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus
Diabetology & Metabolic Syndrome, 9 (2017); 97. https://doi.org/10.1186/s13098-017-0295-0

Božek, Tomislav; Blažeković, Antonela; Nikolac Perković, Matea; Gotovac Jerčić, Kristina; Šustar, Aleksandra; Smirčić-Duvnjak, Lea; Outeiro, Tiago F.; Pivac, Nela; Borovečki, Fran

Citirajte ovaj rad

Božek, T., Blažeković, A., Nikolac Perković, M., Gotovac Jerčić, K., Šustar, A., Smirčić Duvnjak, L. ... Borovečki, F. (2017). The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome, 9., 97. doi: 10.1186/s13098-017-0295-0

Božek, Tomislav, et al. "The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus." Diabetology & Metabolic Syndrome, vol. 9, 2017, str. 97. https://doi.org/10.1186/s13098-017-0295-0

Božek, Tomislav, Antonela Blažeković, Matea Nikolac Perković, Kristina Gotovac Jerčić, Aleksandra Šustar, Lea Smirčić Duvnjak, Tiago F. Outeiro, Nela Pivac i Fran Borovečki. "The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus." Diabetology & Metabolic Syndrome 9 (2017): 97. https://doi.org/10.1186/s13098-017-0295-0

Božek, T., et al. (2017) 'The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus', Diabetology & Metabolic Syndrome, 9, str. 97. doi: 10.1186/s13098-017-0295-0

Božek T, Blažeković A, Nikolac Perković M, Gotovac Jerčić K, Šustar A, Smirčić Duvnjak L, i sur.. The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome [Internet]. 04.12.2017. [pristupljeno 23.07.2024.];9:97. doi: 10.1186/s13098-017-0295-0

T. Božek, et al., "The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus", Diabetology & Metabolic Syndrome, vol. 9, str. 97, Prosinac 2017. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:450360. [Citirano: 23.07.2024.]